Atrium Therapeutics Financials - Benzinga

Atrium Therapeutics Inc

RNANASDAQ

Trade with Public

Trade with Public

$9.56

0.060.63%

At close: Sep 17, 5:00 PM EST

$9.56

N/A

After Hours: 4:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Atrium Therapeutics Financials

Atrium Therapeutics (RNA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Atrium Therapeutics Q2 EPS $(1.18) Misses $(1.01) Estimate, Sales $3.004M Beat $2.000M Estimate

Atrium Therapeutics (NASDAQ:RNA) reported quarterly losses of $(1.18) per share which missed the analyst consensus estimate of $(1.01) by 16.83 percent. This is a 2.48 percent increase over losses of $(1.21) per share

Benzinga Newsdesk

PRO
Atrium Therapeutics Q1 EPS $(0.97) Beats $(1.10) Estimate, Sales $19.635M Beat $2.000M Estimate

Atrium Therapeutics (NASDAQ:RNA) reported quarterly losses of $(0.97) per share which beat the analyst consensus estimate of $(1.10) by 11.82 percent. This is a 7.78 percent decrease over losses of $(0.90) per share from

Benzinga Newsdesk

Novartis Projects Faster Growth Through 2030 After Raising Drug Forecasts

Novartis raises long-term sales targets, boosts outlook for key medicines and outlines a pipeline strategy driving growth through 2030.

Vandana Singh

PRO
Avidity Biosciences Q3 EPS $(1.27) Misses $(1.11) Estimate, Sales $12.475M Beat $1.932M Estimate

Avidity Biosciences (NASDAQ:RNA) reported quarterly losses of $(1.27) per share which missed the analyst consensus estimate of $(1.11) by 13.9 percent. This is a 95.38 percent decrease over losses of $(0.65) per share

Benzinga Newsdesk

Novartis Maintains Outlook Even As Generics Bite Into Profits

Novartis Q3 sales rose 8% to $13.91 billion, missing estimates, as Kisqali and Kesimpta drove growth while U.S. generics weighed on results.

Vandana Singh

Stock Market Today: Nasdaq, Dow Jones, S&P 500 Futures Climb Ahead Of Busy Week On Wall Street—Novartis, Nucor, Waste Management In Focus (UPDATED)

Editor’s note: The future prices of benchmark tracking ETFs, and the headline were updated in the story.

Rishabh Mishra